Skip to content
Recall Observatory FDA recall evidence

Drug product

Nizatidine Oral Solution, 15 mg/mL (75 mg/5mL) USP 480 mL bottles, Rx Only Distributed by: Gemini Laboratories, LLC Bridgewater, NJ 08807 NDC 60846-301-15

D-1253-2020

April 15, 2020

Class II

Product summary

Firm
Amneal Pharmaceuticals of New York, LLC
Event
Event 85386
Status
Terminated
Classification
Class II
Quantity
11258 bottles
Official record key
drug-enforcement:D-1253-2020

Official wording

Reason: CGMP Deviations: potential N-Nitrosodimethylamine (NDMA) amounts above levels established by the FDA.

Code information: 06598004A 04/2020 06599001A 12/2020 06599002A 12/2020

Distribution pattern: Nationwide

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations